Bio Green Med Solution (BGMS) Current Assets (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Current Assets of $5.6 million for Q1 2026, up 51.37% year-over-year from $3.7 million in Q1 2025, and down 10.13% quarter-over-quarter from $6.3 million in Q4 2025.
Analysis
Bio Green Med Solution (BGMS) Current Assets (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Current Assets for 17 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 51.37% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (up 51.37% YoY), while the FY2025 annual figure was $6.3 million, up 70.28% from the prior year.
- Current Assets eased to $5.6 million in Q1 2026 per BGMS's latest filing, from $6.3 million in the prior quarter.
- Across five years, Current Assets topped out at $36.6 million in Q1 2022 and bottomed at $3.7 million in Q4 2024.
- Historically, Current Assets has averaged $13.0 million across 5 years, with a median of $7.4 million in 2023.
- Annual changes were most pronounced in 2024 — Current Assets tumbled 74.52% — and 2025, when it surged 70.28%.
- Bio Green Med Solution's Current Assets stood at $24.4 million in 2022, then plunged by 69.51% to $7.4 million in 2023, then slumped by 50.64% to $3.7 million in 2024, then surged by 70.28% to $6.3 million in 2025, then retreated by 10.13% to $5.6 million in 2026.
- Business Quant data shows BGMS's Current Assets at $5.6 million in Q1 2026, $6.3 million in Q4 2025, and $6.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.68 Bn | 133.83 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 87.47 Bn | 79.47 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.12 Bn | 52.98 Bn | 52.00 Mn | 5.82 Bn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 4.03 Bn |
| 6 | BeOne Medicines | 40.55 Bn | 35.45 Bn | 1.53 Bn | 7.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Royalty Pharma | 28.15 Bn | 27.31 Bn | - | 1.76 Bn |
| 9 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Bio Green Med Solution | 5.50 Mn | 1.71 Mn | 79,000.00 | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.97 Mn |
| Mar 31, 2026 | 5.62 Mn |
| Dec 31, 2025 | 6.26 Mn |
| Sep 30, 2025 | 6.44 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 3.71 Mn |
| Dec 31, 2024 | 3.67 Mn |
| Sep 30, 2024 | 4.91 Mn |
| Jun 30, 2024 | 7.71 Mn |
| Mar 31, 2024 | 4.84 Mn |
| Dec 31, 2023 | 7.44 Mn |
| Sep 30, 2023 | 11.11 Mn |
| Jun 30, 2023 | 15.29 Mn |
| Mar 31, 2023 | 18.97 Mn |
| Dec 31, 2022 | 24.41 Mn |
| Sep 30, 2022 | 27.92 Mn |
| Jun 30, 2022 | 32.08 Mn |
| Mar 31, 2022 | 36.58 Mn |
| Dec 31, 2021 | 40.94 Mn |
| Sep 30, 2021 | 43.38 Mn |